Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 69, Issue 1, 2008, Pages 83-93

  Grenha, Ana ^a   Remuñán López, Carmen ^a   Carvalho, Edison L S ^a   Seijo, Begoña ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Chitosan nanoparticles; Dry powders; Microspheres; Phospholipids; Pulmonary delivery; Spray drying

Indexed keywords

CHITOSAN; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; INSULIN; MANNITOL; MICROSPHERE; NANOPARTICLE; PHOSPHOLIPID; PROTASAN; TRIPOLYPHOSPHATE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; MICROENCAPSULATION; PHYSICAL CHEMISTRY; SPRAY DRYING;

CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; INSULIN; LIPIDS; LUNG; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; NANOPARTICLES; POLYPHOSPHATES; POWDERS; TECHNOLOGY, PHARMACEUTICAL;

EID: 41549155028     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.10.017     Document Type: Article

References (61)

1. Edwards D.A., Ben-Jebria A., and Langer R. Recent advances in pulmonary drug delivery using large, porous inhaled particles. J. Appl. Physiol. 84 (1998) 379-385
2. Bosquillon C., Lombry C., Préat V., and Vanbever R. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J. Control. Release 70 (2001) 329-339
3. Courrier H.M., Butz N., and Vandamme T.F. Pulmonary drug delivery systems: recent developments and prospects. Crit. Rev. Ther. Drug Carr. Syst. 19 (2002) 425-498
4. Oberdörster G., Oberdörster E., and Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113 (2005) 823-839
5. Sharma A., and Sharma U.S. Liposomes in drug delivery: progress and limitations. Int. J. Pharm. 154 (1997) 123-140
6. Kirby C.J., and Gregoriadis G. Liposomes. In: Mathiowitz E. (Ed). Encyclopedia of Controlled Drug Delivery (1999), John Wiley & Sons, New York 461-492
7. Mezei M. Liposomes in the topical application of drugs: a review. In: Gregoriadis G. (Ed). Liposomes as Drug Carriers: Recent Trends and Progress (1988), John Wiley & Sons, Chichester 663-677
8. Mihalko P.J., Schreier H., and Abra R.M. Liposomes: a pulmonary perspective. In: Gregoriadis G. (Ed). Liposomes as Drug Carriers: Recent Trends and Progress (1988), John Wiley & Sons, Chichester 679-694
9. Antimisiaris S.G., Jayasekera P., and Gregoriadis G. Liposomes as vaccine carriers. Incorporation of soluble and particulate antigens in giant vesicles. J. Immunol. Methods 166 (1993) 271-280
10. Arrault J., Grand C., Poon W.C.K., and Cates M.E. Stuffed onions: particles in multilamellar vesicles. Europhys. Lett. 38 (1997) 625-630
11. McPhail D., Tetley L., Dufes C., and Uchegbu I.F. Liposomes encapsulating polymeric chitosan based vesicles - a vesicle in vesicle system for drug delivery. Int. J. Pharm. 200 (2000) 73-86
12. Moya S., Donath E., Sukhorukov G.B., Auch M., Bäumler H., Lichtenfeld H., and Möhwald H. Lipid coating on polyelectrolyte surface modified colloidal particles and polyelectrolyte capsules. Macromolecules 33 (2000) 4538-4544
13. Campbell A., Taylor P., Cayre O.J., and Paunov V.N. Preparation of aqueous gel beads coated by lipid bilayers. Chem. Commun. 21 (2004) 2378-2379
14. E.L.S. Carvalho, B. Seijo, M.J. Alonso, Lipid-chitosan nanoparticle complexes (L/CS-Np) for oral insulin delivery: preparation, characterization and in vivo evaluation. Int. J. Pharm. (submitted).
15. Jain S., Sharma R.K., and Vyas S.P. Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization. J. Pharm. Pharmacol. 58 (2006) 303-310
16. Fery A., Moya S., Puech P.-H., Brochard-Wyart F., and Mohwald H. Interaction of polyelectrolyte coated beads with phospholipid vesicles. C. R. Phys. 4 (2003) 259-264
17. Correia F.M., Petri D.F.S., and Carmona-Ribeiro A.M. Colloid stability of lipid/polyelectrolyte decorated latex. Langmuir 20 (2004) 9535-9540
18. Troutier A.-L., Delair T., Pichot C., and Ladavière C. Physicochemical and interfacial investigation of lipid/polymer particle assemblies. Langmuir 21 (2005) 1305-1313
19. Liu F., Shao Z., Kildsig D.O., and Mitra A.K. Pulmonary delivery of free and liposomal insulin. Pharm. Res. 10 (1993) 228-232
20. McAllister S.M., Alpar H.O., Teitelbaum Z., and Bennett D.B. Do interactions with phospholipids contribute to the prolonged retention of polypeptides within the lung?. Adv. Drug Deliv. Rev. 19 (1996) 89-110
21. Mitra R., Pezron I., Li Y., and Mitra A.K. Enhanced pulmonary delivery of insulin by lung lavage fluid and phospholipids. Int. J. Pharm. 217 (2001) 25-31
22. Clark A. Formulation of proteins and peptides for inhalation. Drug Deliv. Syst. Sci. 2 (2002) 73-77
23. Rudt S., and Müller R.H. In vitro phagocytosis of nano- and microparticles by chemiluminescence. I. Effect of analytical parameters, particle size and particle concentration. J. Control. Release 22 (1992) 263-272
24. Ahsan F., Rivas I.P., Khan M.A., and Suárez-Torres A.I. Targeting to macrophages: role of physicochemical properties of particulate carriers - liposomes and microspheres - on the phagocytosis by macrophages. J. Control. Release 79 (2002) 29-40
25. Makino K., Yamamoto H., Higuchi K., Harada N., Ohshima H., and Terada H. Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres. Colloids. Surf. B - Biointerfaces 27 (2003) 33-39
26. Evora C., Soriano I., Rogers R.A., Shakesheff K.M., Hanes J., and Langer R. Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine. J. Control. Release 51 (1998) 143-152
27. Kreuter J. Liposomes and nanoparticles as vehicles for antibiotics. Infection 19 (1991) S224-S228
28. Alonso M.J. Nanoparticulate drug carrier technology. In: Cohen S., and Bernstein H. (Eds). Microparticulate systems for the Delivery of Proteins and Vaccines (1996), Marcel Dekker, New York 203-242
29. Zhang Q., Shen Z., and Nagai T. Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. Int. J. Pharm. 218 (2001) 75-80
30. Tsapis N., Bennet D., Jackson B., Weitz D.A., and Edwards D.A. Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc. Nat. Acad. Sci. 99 (2002) 12001-12005
31. Dailey L.A., Kleemann E., Wittmar M., Gessler T., Schmehl T., Roberts C., Seeger W., and Kissel T. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA. Pharm. Res. 20 (2003) 2011-2020
32. Grenha A., Seijo B., and Remuñan-Lopez C. Microencapsulated chitosan nanoparticles for lung protein delivery. Eur. J. Pharm. Sci. 25 (2005) 427-437
33. Hirano S., Seino H., Akiyama Y., and Nonaka I. Biocompatibility of chitosan by oral and intravenous administrations. Polym. Mater. Sci. Eng. 59 (1988) 897-901
34. Lehr C.M., Bouwstra J.A., Schacht E.H., and Junginger H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78 (1992) 43-48
35. Dornish M., Hagen A., Hansson E., Peucheur C., Vedier F., and Skaugrud O. Safety of ProtasanTM: ultrapure chitosan salts for biomedical and pharmaceutical use. In: Domard A., Roberts G.A.F., and Varum K.M. (Eds). Advances in Chitin Science (1997), Jacques Andre Publisher, Lyon 664-670
36. Lim S.T., Forbes B., Martin G.P., and Brown M.B. In vivo and in vitro characterization of novel microparticulates based on hyaluronan and chitosan hydroglutamate. AAPS PharmsciTech. 2 (2001) 1-14
37. Florea B.I., Thanou M., Junginger H.E., and Borchard G. Enhancement of bronchial octreotide absorption by chitosan and N-trimethylchitosan shows linear in vitro/in vivo correlation. J. Control. Release 110 (2005) 353-361
38. Calvo P., Remuñan-Lopez C., Vila-Jato J.L., and Alonso M.J. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63 (1997) 125-132
39. Fernandez-Urrusuno R., Calvo P., Remuñan-Lopez C., Vila-Jato J.L., and Alonso M.J. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 16 (1999) 1576-1581
40. Fernandez-Urrusuno R., Romani D., Calvo P., Vila-Jato J.L., and Alonso M.J. Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration. S.T.P. Pharma Sci. 9 (1999) 429-436
41. de Campos A., Sanchez A., and Alonso M.J. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin. Int. J. Pharm. 224 (2001) 159-168
42. Behrens I., Vila-Pena A.I., Alonso M.J., and Kissel T. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm. Res. 19 (2002) 1185-1193
43. Grenha A., Grainger C.I., Dailey L.A., Seijo B., Martin G.P., Remuñán-López C., and Forbes B. Chitosan nanoparticle-containing microspheres are compatible with respiratory epithelial cells in vitro. Eur. J. Pharm. Sci. 31 (2007) 73-84
44. Goldbach P., Brochart H., and Stamm A. Spray-drying of liposomes for a pulmonary administration. I. Chemical stability of phospholipids. Drug Dev. Ind. Pharm. 19 (1993) 2611-2622
45. Freitas C., and Müller R.H. Spray-drying of solid lipid nanoparticles (SLNTM). Eur. J. Pharm. Biopharm. 46 (1998) 145-151
46. Beaulac C., Sachetelli S., and Lagacé J. Aerosolization of low phase transition temperature liposomal tobramycin as dry powder in an animal model of chronic pulmonary infection caused by Pseudomonas aeruginosa. J. Drug Target. 7 (1999) 33-41
47. Weiner A.L. Liposomes as carriers for polypeptides. Adv. Drug Deliv. Rev. 3 (1989) 307-341
48. Marier J.-F., Lavigne J., and Ducharme M.P. Pharmacokinetics and efficacies of liposomal and conventional formulations of tobramycin after intratracheal administration in rats with pulmonary Burkholderia cepacia infection. Antimicrob. Agents Chemother. 46 (2002) 3776-3781
49. El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres. Int. J. Pharm. 294 (2002) 7-21
50. Wright J.R., and Clements J.A. Metabolism and turnover of lung surfactant. Am. Rev. Respir. Dis. 135 (1987) 426-444
51. Taylor K.M.G., and Craig D.Q.M. Physical methods of study: differential scanning calorimetry. In: Torchilin V.P., and Weissig V. (Eds). Liposomes (2003), Oxford University Press, Oxford 70-103
52. Fattal E., Couvreur P., and Puisieux F. Méthodes de préparation des liposomes. In: Delattre J., Couvreur P., Puisieux F., Philippot J.R., and Schuber F. (Eds). Les Liposomes: Aspects technologiques, biologiques et pharmacologiques (1993), Editions Inserm, Paris 43-52
53. Makino K., Yamada T., Kimura M., Oka T., Oshima H., and Kondo T. Temperature and ionic strength induced conformational changes in the lipid head group region of liposomes as suggested by zeta potential data. Biophys. Chem. 41 (1991) 175-183
54. Chupin V., de Kroon A.I.P.M., and de Kruijff B. Molecular architecture of nanocapsules, bilayer-enclosed solid particles of cisplatin. JACS 126 (2004) 13816-13821
55. Diebold Y., Jarri{dotless}́n M., Sáez V., Carvalho E.L.S., Orea M., Calonge M., Seijo B., and Alonso M.J. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 28 (2007) 1553-1564
56. Grenha A., Seijo B., Serra C., and Remuñán-López C. Chitosan nanoparticle-loaded mannitol microspheres: structure and surface characterization. Biomacromolecules 8 (2007) 2072-2079
57. Broadhead J., Edmond-Rouan S.K., and Rhodes C.T. The spray drying of pharmaceuticals. Drug Dev. Ind. Pharm. 18 (1992) 1169-1206
58. Okamoto H., Todo H., Iida K., and Danjo K. Dry powders for pulmonary delivery of peptides and proteins. Kona. 20 (2002) 71-83
59. Taylor G., and Kellaway I. Pulmonary drug delivery. In: Hillery A., Lloyd A., and Swarbrick J. (Eds). Drug Delivery and Targeting. For Pharmacists and Pharmaceutical Scientists (2001), Taylor & Francis, New York 269-300
60. Kyle H., Ward J.P., and Widdicombe J.G. Control of pH of airway surface liquid of the ferret trachea in vitro. J. Appl. Physiol. 68 (1990) 135-140
61. Walters D.V. Lung lining liquid - the hidden depths. Biol. Neonate 81 (2002) 2-5